Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0602 USD | -0.50% | -14.37% | -53.66% |
Apr. 19 | Fed Rate Pessimism Pushes Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday | MT |
Apr. 19 | Bruush Oral Care Notified of Additional Deficiency Against Nasdaq Listing Rules | MT |
Valuation
Fiscal Period: October | 2022 |
---|---|
Capitalization 1 | 8.291 |
Enterprise Value (EV) 1 | 8.189 |
P/E ratio | -0.6 x |
Yield | - |
Capitalization / Revenue | 3.15 x |
EV / Revenue | 3.11 x |
EV / EBITDA | -792,919 x |
EV / FCF | -890,183 x |
FCF Yield | -0% |
Price to Book | -6.33 x |
Nbr of stocks (in thousands) | 304 |
Reference price 2 | 27.25 |
Announcement Date | 3/10/23 |
Income Statement Evolution (Annual data)
Fiscal Period: October | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales 1 | 0.2074 | 2.621 | 2.632 |
EBITDA | - | -5.471 | -10.33 |
EBIT 1 | -1.362 | -5.479 | -10.34 |
Operating Margin | -656.68% | -209.07% | -392.9% |
Earnings before Tax (EBT) 1 | -1.379 | -5.615 | -8.765 |
Net income 1 | -1.379 | -5.615 | -8.765 |
Net margin | -664.82% | -214.27% | -332.97% |
EPS 2 | -32.69 | -35.72 | -45.64 |
Free Cash Flow | - | 0.5743 | -9.199 |
FCF margin | - | 21.91% | -349.45% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 5/26/22 | 7/1/22 | 3/10/23 |
Balance Sheet Analysis
Fiscal Period: October | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | 0.25 | 0.01 | - |
Net Cash position 1 | - | - | 0.1 |
Leverage (Debt/EBITDA) | - | -0.002305 x | - |
Free Cash Flow | - | 0.57 | -9.2 |
ROE (net income / shareholders' equity) | - | -7,167% | 328% |
ROA (Net income/ Total Assets) | - | -364% | -577% |
Assets 1 | - | 1.544 | 1.52 |
Book Value Per Share 2 | 2.010 | -0.2600 | -4.300 |
Cash Flow per Share 2 | 4.280 | 0 | 0.2200 |
Capex | - | 0.01 | 0 |
Capex / Sales | - | 0.32% | 0.08% |
Announcement Date | 5/26/22 | 7/1/22 | 3/10/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.66% | 2.6M | |
+34.35% | 33.03B | |
+63.74% | 8.42B | |
+106.62% | 7.43B | |
-21.95% | 5.19B | |
+38.56% | 4.56B | |
+16.95% | 3.51B | |
+41.71% | 3.43B | |
+12.08% | 3.19B | |
+4.37% | 3.16B |
- Stock Market
- Equities
- BRSH Stock
- Financials Bruush Oral Care Inc.